Literature DB >> 7108171

Private and public initiatives in health maintenance organizations.

D H Harrison, J R Kimberly.   

Abstract

Public policy controversies about the cost-containing potential of HMOs and the failures of many plans should not overshadow the fact that HMOs will be forces in the health care sector in the 1980s, largely as the result of increasing private investment. There is a large, stable segment of the prepaid industry that developed as a result of private sector and community concern long before the federal HMO Act of 1973, and it is their initiatives along with increasing investment activity by insurance companies and management companies in particular, that will serve as a base for consolidation and growth of HMO plans. HMOs have not proved to be the miraculous cost-containing mechanism of the future, but their impact will be felt even more for the changes they stimulate in the customary organizational forms, in financing, and in the role of business in health care.

Mesh:

Year:  1982        PMID: 7108171     DOI: 10.1215/03616878-7-1-80

Source DB:  PubMed          Journal:  J Health Polit Policy Law        ISSN: 0361-6878            Impact factor:   2.265


  2 in total

1.  Effector differentiation downstream of lineage commitment in ILC1s is driven by Hobit across tissues.

Authors:  Christin Friedrich; Renske L R E Taggenbrock; Rémi Doucet-Ladevèze; Gosia Golda; Rebekka Moenius; Panagiota Arampatzi; Natasja A M Kragten; Katharina Kreymborg; Mercedes Gomez de Agüero; Wolfgang Kastenmüller; Antoine-Emmanuel Saliba; Dominic Grün; Klaas P J M van Gisbergen; Georg Gasteiger
Journal:  Nat Immunol       Date:  2021-08-30       Impact factor: 25.606

2.  BACH2 enforces the transcriptional and epigenetic programs of stem-like CD8+ T cells.

Authors:  Chen Yao; Guohua Lou; Hong-Wei Sun; Ziang Zhu; Yi Sun; Zeyu Chen; Daniel Chauss; E Ashley Moseman; Jun Cheng; Marc A D'Antonio; Wangke Shi; Junwei Shi; Kohei Kometani; Tomohiro Kurosaki; E John Wherry; Behdad Afzali; Luca Gattinoni; Yuwen Zhu; Dorian B McGavern; John J O'Shea; Pamela L Schwartzberg; Tuoqi Wu
Journal:  Nat Immunol       Date:  2021-02-11       Impact factor: 25.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.